Skip to content
Thursday, October 15, 2026
FuturePortal.de is a blog dedicated to cutting-edge tech, A…

Individuals Coming Off Weight-Loss Medications Put On Pounds at a Quadrupled Rate Than People Using Diet and Exercise

Image of pharmaceutical syringe and weighing machine
Obesity treatment often requires long-term strategies.

A recent study suggests that individuals who come off blockbuster weight-loss injections like Mounjaro or Wegovy tend to recover reduced body mass far faster than those who stop conventional lifestyle regimens.

Findings released in a prominent medical journal demonstrates that while overweight people often shed about a fifth of their body weight while undergoing treatment, the weight comes back at an estimated rate of nearly a kilo each month once they quit.

"Individuals purchasing these drugs should be informed of the risk of fast rebound weight gain when the treatment ends," warns researcher Dr. Susan Jebb.

This pace of recovery suggests a reversion to starting mass within about a year and a half.

Weighing Approaches

The analysis, which looked at dozens of trials involving over 9,000 of participants, contrasted the effects of these new drugs with conventional dieting.

Researchers emphasize that people who shed pounds through lifestyle changes alone typically experience a slower creep back—perhaps 0.1 kg a month—after stopping.

Explaining the Rapid Regain

Nutrition scientists believe the way of the drugs accounts for the heightened regain.

These medications mimic a body's own chemical called glucagon-like peptide-1, which moderates feelings of fullness.

"Sustained high doses of the hormone concentrations far above than normal could lead to the system to generate a reduced amount of its endogenous GLP-1, and may also lessen sensitivity to its actions," noted Dr. Adam Collins, a nutrition expert.

"Stopping of this medication means appetite is unsuppressed, making overeating far more likely."

A Chronic Condition?

The NHS suggest the injections for people with obesity-related medical conditions, alongside recommended lifestyle changes.

A number of clinicians argue that, considering the high risk of weight regain, the treatment might need to be ongoing.

This view is reinforced by drug manufacturers, who say that the findings "underscore the chronic character of obesity," akin to managing diseases like high blood pressure.

User Accounts

People who have come off the medication explain a intense resurgence of appetite.

"It felt as if a switch activating and you're instantly ravenous," described a patient.

This difficulty is exacerbated if patients have not adopted permanent lifestyle or habit modifications during therapy.

Growing Adoption

Figures indicate that a significant number of adults in the UK have used these injections in the last 12 months, with interest remaining high.

  • Adoption is higher among females than males.
  • The middle-aged age group shows the highest usage rates.
  • A large proportion access the medications through private healthcare rather than public health services.

In conclusion, researchers emphasize that while these medications are powerful tools for shedding pounds, they are not a permanent cure and lasting health benefits likely depends on ongoing lifestyle management.

About the author

Marissa Massey

A tech journalist and futurist with a passion for exploring how emerging technologies shape society and daily life.

FuturePortal

Type to search articles.